Nasdaq

Intec Pharma and Decoy Biosystems Announce Merger Agreement

JERUSALEM, March 15, 2021 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") announced today that it has entered into a definitive agreement for a business combination with ...
Nasdaq

Intec Pharma Highlights Potential of Accordion Pill® Oral Drug Delivery Platform in Two Posters at International Congress of Parkinson's and Movement Disorder Society

JERUSALEM, Sept. 25, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that two posters highlighting data from the Company's Phase 3 clinical development ...
POWER Magazine

INTEC Chosen to Build 50-MW Solar Power Facility in Germany

Global renewable energy contractor INTEC Energy Solutions has been selected by a leading European renewable energy investment group to lead construction of a 50-MW solar power plant in Lachendorf, ...
FierceBiotech

Intec posts early data on controlled-release cannabis pill

Intec Pharma has posted data from a phase 1 trial of its cannabinoid candidate. The early look at the pharmacokinetics achieved by delivering cannabidiol (CBD) and tetrahydrocannabinol (THC) via Intec ...
CRN

inTEC CEO Melissa Rambridge: ‘This is the mark of a new era’

Rambridge tells CRN the business is on an M&A break and focusing on how to become one combined entity following 14 acquisitions in eight years inTEC has marked a new era for the business with a newly ...